beat – Talk Bio

Actionable Insights Powered by AI

Puma Biotechnology Reports Third Quarter 2025 Financial Results

1 month ago talkbio0Tagged beat, Clinical Trials, EPS, exophthalmos producing substance, financial results, Neoplasms, Nerlynx sales, net income, Puma Biotechnology, Q3, Revenue Decline, revenue guidance

Puma Biotechnology; Q3 2025; financial results; EPS beat; revenue decline; Nerlynx sales; net income; oncology; clinical trials; revenue guidance

NFL Legend Jerome Bettis Joins CDC Foundation’s “Live to the Beat” Campaign to Tackle Heart Health in Black Community

10 months ago talkbio0Tagged beat, Bettis, Black Populations, Cardiovascular Diseases, Centers for Disease Control and Prevention (U.S.), Community, Foundations, heart health, Hypertensive disease, Jerome, NEFL gene

Jerome Bettis, CDC Foundation, Live to the Beat, cardiovascular disease, Black community, hypertension, heart health, NFL

Syndax’s Revumenib Shows Promising Results in Acute Leukemia Trials, Paving Way for FDA Approval

1 year ago talkbio0Tagged Acute leukemia, Approved, AUGMENT-101, beat, BEAT AML, Commit Operation, Leukemia, Myelocytic, Acute, revumenib, Syndax, United States Food and Drug Administration

Revumenib, Acute Leukemia, AUGMENT-101, SAVE Trial, BEAT AML, Syndax Pharmaceuticals, FDA Approval